Trial Profile
Open-label, Sequential trial Investigating the Pharmacokinetic Interaction between Pradigastat and Efavirenz or Repaglinide in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Oct 2014
Price :
$35
*
At a glance
- Drugs Pradigastat (Primary) ; Efavirenz; Repaglinide
- Indications Hyperlipoproteinaemia type I
- Focus Pharmacokinetics
- 14 Oct 2014 New trial record